Bioactivity:

Romidepsin is an intravenously administered histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous and peripheral T cell lymphomas.

CAS nr:

128517-07-7

Purity:

98%

Molecular Weight:

540,7

SMILES:

C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C

Formula:

C24H36N4O6S2

Pathway:

Apoptosis,DNA Damage/DNA Repair,Chromatin/Epigenetic

Target:

Apoptosis,HDAC,HDAC